Wacker and Pantherna intensify collaboration in the development and production of mRNA biopharmaceuticals
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Studies will Investigate Antidepressant Properties of Ketamir to Position for Initial IND Application in 2024
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Bridging the gap between histopathology and molecular pathology
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Subscribe To Our Newsletter & Stay Updated